UK urged to modernize AI medical device regulations

An advisory panel has called on the UK to revise its regulatory framework for AI-powered medical devices, advocating for a phased approval system that incorporates ongoing oversight. The recommendation aims to enhance patient safety by ensuring devices are continuously monitored post-approval. The panel emphasized the need for a more adaptive regulatory approach to keep pace with technological advancements. According to Dr. Emily Carter, a leading medical technology expert, the current system lacks the flexibility required to address emerging risks effectively. She stated, "A static regulatory model is insufficient for the dynamic nature of AI in healthcare." The call for reform comes amid growing concerns about the safety and efficacy of AI-driven medical technologies. The UK's National Health Service is under pressure to balance innovation with patient protection, as the sector continues to evolve rapidly. The advisory panel also highlighted the importance of transparency in the approval process, urging regulators to engage with stakeholders throughout development. This includes healthcare professionals, patients, and technology developers. The panel's recommendations are expected to inform upcoming policy discussions, with a focus on creating a regulatory environment that fosters innovation while safeguarding public health. The UK government has yet to respond to the call for reform, but the advisory panel's findings are likely to influence future regulatory decisions in the sector.